AECI aims to generate revenue of about R4bn from its plant and animal health businesses by 2020, CEO Mark Dytor says. Speaking after a presentation to analysts on Tuesday, Dytor said the group was strategically pushing into the rest of Africa with new intellectual property and products. It was also looking at overseas markets. The plant and animal health arm generates about R3bn. "We are aiming to get it up to 10% of trading profit in the next two years," said Dytor. AECI may invest in start-up agrichemicals businesses with good intellectual property portfolios, and there were many more efficiencies to be derived in terms of crop yields, he said. Meanwhile, much of Africa was water stressed. "New technology will help reduce water consumption in growing food," Dytor said. Commenting on the presentation — which focused on AECI’s agribusiness, Nulandis — Mish-al Emeran, equity analyst at Electus Fund Managers, said AECI would be reporting its business segments in five strategic pillars...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now